BIOHAVEN PHARMACEUTICAL HOLDING CO LTD. : Conclusion of a material definitive agreement, financial statements and supporting documents (form 8-K)

Item 1.01 Entry into a Material Definitive Agreement.

Sixth Street Funding Agreement Amendment

At September 30, 2021, Biohaven Pharmaceutical Holding Company Ltd. (the company “), Biohaven Pharmaceuticals, Inc., a wholly owned subsidiary of the Company (together with the Company, the “Borrowers”), and certain other subsidiaries of the Company, the lenders parties thereto and Sixth Street Specialty Lending, Inc., as administrative agent , concluded an amendment n ° 2 to the financing agreement (the “second addendum”) to its financing agreement dated August 7, 2020 (as previously amended and as amended by the Second Amendment, the “Sixth Street Funding Agreement”). Under the Second Amendment, the parties agreed, inter alia, to increase the total size of the credit facility by providing for an additional term loan in the aggregate principal amount of $ 125.0 million (the “2021 Term Loan”) and additional deferred drawing term loan commitments for a total principal amount of $ 125.0 million (the “DDTL 2021 Commitment”). At closing this resulted in a total of $ 350.0 million in the financing available to Borrowers, and Borrowers drew a total of $ 225.0 million (comprising the 2021 term loan and a deferred drawing term loan for a total principal amount of $ 100.0 million contracted under existing deferred drawing term loan commitments). The supplement $ 125.0 million of the 2021 DDTL Commitment remains available at the Borrowers’ discretion for prior drawing.
December 31, 2021.

The 2021 term loan and the deferred drawing term loans financed under the 2021 DDTL commitment will bear variable interest on the principal amount outstanding at an annual rate equal to the three-month LIBOR rate, adjusted for the applicable minimum reserves, and subject to a floor of 1.00%, plus 8.25%. Interest on amounts borrowed under the facility will be payable quarterly. Except as described herein, the principal terms of the Sixth Street Funding Agreement, including payment in kind, prepayments and customary charges, remain as set out in Sixth Street Funding Agreement as in effect prior to the Second Amendment. The second amendment will be filed as an attachment to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2021.

Item 9.01 Financial statements and supporting documents.

(d) Exhibits

       Exhibit Number                                 Exhibit Description
            104              The cover page of this Current Report on Form 8-K formatted as Inline
                             XBRL.


                                       2

————————————————– ——————————-

© Edgar online, source Previews